Insider Transactions in Q3 2023 at Heron Therapeutics, Inc. (HRTX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 22
2023
|
Craig A Collard Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
692
-1.86%
|
$692
$1.65 P/Share
|
|
Jul 25
2023
|
Lisa Peraza VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,743
-21.7%
|
$14,743
$1.51 P/Share
|
|
Jul 25
2023
|
Lisa Peraza VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
42,631
+38.56%
|
-
|
|
Jul 21
2023
|
Adam Morgan Director |
BUY
Open market or private purchase
|
Indirect |
2,486,744
+26.25%
|
$2,486,744
$1.37 P/Share
|
|
Jul 13
2023
|
Lisa Peraza VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
860
-3.29%
|
$860
$1.31 P/Share
|
|
Jul 13
2023
|
Lisa Peraza VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,485
+4.55%
|
-
|
|
Jul 13
2023
|
David Leslie Szekeres EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,012
-5.63%
|
$2,012
$1.31 P/Share
|
|
Jul 13
2023
|
David Leslie Szekeres EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,814
+7.58%
|
-
|